Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HELP

Cybin D/B/A Helus Pharma

Healthcare · USD

Set alert

Price alert · HELP

All alert types
10.60 USD -0.12 -1.07%
As of Oct 30, 2026 Extended hours 10.50 -0.90%
Bid
10.57 × 2
Ask
10.63 × 2
10.42 Day range 10.97
3.87 52-week range 14.02
YTD
+29.52%
1 year
+47.56%
Open
10.53
Prev close
10.71
Mkt cap
774.17M
Vol
1.15M
Avg vol
1.70M
EPS
-4.15
P/E
0.00
Div yield
0.00%
More statistics
Low
10.42
High
10.97
Forward P/E
-7.55
Beta
0.63
Short ratio
1.59
Inst. own
41.29%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
10.70
200-d avg
7.11
1y target
40.24

MAX chart

Chart tools
Interval
1m5m15m30m
HELP all-time price chart2.9634.365.797.1128.4Sep 19Feb 21Jul 22Dec 23May 25Oct 26

Financial health

Altman Z-Score

26.44 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.1×
FY 2017: -21.1×FY 2018: -11.1×FY 2019: -27.8×FY 2020: -5.6×FY 2021: -0.6×FY 2022: -0.5×FY 2023: -0.8×FY 2024: -2.0×FY 2025: -1.5×FY 2026: -1.1×
FY 2017 5y median -1.1× FY 2026
P/S -3.7×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 22.6×FY 2022: 194×FY 2023: 155×FY 2024: 0.0×FY 2025: 364×FY 2026: -3.7×
FY 2017 5y median 155× FY 2026
P/B 0.7×
FY 2017: 9.1×FY 2018: 5.6×FY 2019: 7.2×FY 2020: 6.1×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.8×FY 2024: 0.5×FY 2025: 0.7×FY 2026: 0.7×
FY 2017 5y median 0.7× FY 2026
P/FCF -1.2×
FY 2017: -370×FY 2018: -10.0×FY 2019: -24.0×FY 2020: -6390×FY 2021: -1.0×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -2.3×FY 2025: -1.7×FY 2026: -1.2×
FY 2017 5y median -1.2× FY 2026
EV/EBITDA -0.1×
FY 2017: -17.5×FY 2018: -9.2×FY 2019: -31.3×FY 2020: -18259×FY 2021: 1.4×FY 2022: 0.3×FY 2023: -0.4×FY 2024: 0.6×FY 2025: -0.3×FY 2026: -0.1×
FY 2017 5y median -0.1× FY 2026
EV/Sales -0.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -51.5×FY 2022: -126×FY 2023: 89.0×FY 2024: 0.0×FY 2025: 78.2×FY 2026: -0.2×
FY 2017 5y median 0.0× FY 2026
FCF Yield -80.1%
FY 2017: -0.3%FY 2018: -10.0%FY 2019: -4.2%FY 2020: -0.0%FY 2021: -98.6%FY 2022: -140.6%FY 2023: -130.2%FY 2024: -43.6%FY 2025: -60.1%FY 2026: -80.1%
FY 2017 5y median -80.1% FY 2026

Profitability

Gross Margin 100.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -36.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 100.3%
FY 2017 5y median 0.0% FY 2026
Operating Margin 317.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -3592.0%FY 2022: -38053.2%FY 2023: -20523.9%FY 2024: 0.0%FY 2025: -30310.4%FY 2026: 317.1%
FY 2017 5y median -20523.9% FY 2026
Net Margin 329.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -3729.2%FY 2022: -40314.1%FY 2023: -18919.2%FY 2024: 0.0%FY 2025: -23956.0%FY 2026: 329.1%
FY 2017 5y median -18919.2% FY 2026
ROE -63.3%
FY 2017: -43.4%FY 2018: -50.2%FY 2019: -25.6%FY 2020: -134.3%FY 2021: -37.4%FY 2022: -88.8%FY 2023: -98.5%FY 2024: -26.7%FY 2025: -47.7%FY 2026: -63.3%
FY 2017 5y median -63.3% FY 2026
ROIC -60.9%
FY 2017: -43.4%FY 2018: -43.1%FY 2019: -20.4%FY 2020: -134.9%FY 2021: -35.6%FY 2022: -83.6%FY 2023: -106.2%FY 2024: -27.0%FY 2025: -60.1%FY 2026: -60.9%
FY 2017 5y median -60.9% FY 2026
ROA -58.4%
FY 2017: -28.7%FY 2018: -48.4%FY 2019: -24.7%FY 2020: -113.6%FY 2021: -35.0%FY 2022: -80.5%FY 2023: -88.1%FY 2024: -25.9%FY 2025: -43.7%FY 2026: -58.4%
FY 2017 5y median -58.4% FY 2026

Growth (YoY)

Revenue -9561.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -80.6%FY 2023: 49.6%FY 2024: -100.0%FY 2025: 0.0%FY 2026: -9561.6%
FY 2017 FY 2026
Operating Income 1.0%
FY 2017: 0.0%FY 2018: -49.6%FY 2019: 57.6%FY 2020: -2326.7%FY 2021: -1488.3%FY 2022: -105.7%FY 2023: 19.3%FY 2024: -53.0%FY 2025: -81.6%FY 2026: 1.0%
FY 2017 FY 2026
EPS (diluted) 24.3%
FY 2017: 0.0%FY 2018: -97.1%FY 2019: 59.4%FY 2020: -550.0%FY 2021: -572.5%FY 2022: -25.5%FY 2023: 36.6%FY 2024: 3.4%FY 2025: 40.6%FY 2026: 24.3%
FY 2017 FY 2026
Free Cash Flow -29.6%
FY 2017: 0.0%FY 2018: -3338.1%FY 2019: 51.9%FY 2020: 98.8%FY 2021: -1390570.1%FY 2022: -137.4%FY 2023: -11.0%FY 2024: -37.2%FY 2025: -48.3%FY 2026: -29.6%
FY 2017 FY 2026

Financial Health

Current Ratio 9.5×
FY 2017: 2.9×FY 2018: 27.4×FY 2019: 23.3×FY 2020: 6.2×FY 2021: 13.6×FY 2022: 7.4×FY 2023: 4.1×FY 2024: 21.6×FY 2025: 7.7×FY 2026: 9.5×
FY 2017 5y median 7.7× FY 2026
Quick Ratio 9.5×
FY 2017: 2.9×FY 2018: 27.4×FY 2019: 23.3×FY 2020: 6.2×FY 2021: 13.6×FY 2022: 7.4×FY 2023: 4.1×FY 2024: 21.6×FY 2025: 7.7×FY 2026: 9.5×
FY 2017 5y median 7.7× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.1×
FY 2017: 3.4×FY 2018: 2.0×FY 2019: 3.9×FY 2020: 3863×FY 2021: 2.1×FY 2022: 0.8×FY 2023: 0.3×FY 2024: 2.7×FY 2025: 0.9×FY 2026: 1.1×
FY 2017 5y median 0.9× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -3104×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31